The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

The case stems from a Leawood woman who sought a religious exemption from the COVID-19 vaccine requirement for an ...

Key Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.

A spring Covid-19 booster vaccination programme for vulnerable groups has started. The HSE said it is aimed at those most at ...

A South Carolina Senate committee rejected the Republican governor’s nominee to be the state’s top doctor after hours of ...

Hospital staff are urging vulnerable people to take the covid vaccine after a spike in cases across the North West - with Bolton among ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

For many this will be their fifth year of getting Covid vaccines – and some will ask if it is still worth getting the jab.

In a series of interviews, experts highlight lasting health care innovations that emerged during the COVID-19 pandemic, including telemedicine, artificial intelligence (AI), and home-based treatment.